Edition:
Deutschland

Altria Group Inc (MO.N)

MO.N on New York Stock Exchange

63.34USD
22 Feb 2018
Change (% chg)

$-0.59 (-0.92%)
Prev Close
$63.93
Open
$64.04
Day's High
$65.09
Day's Low
$63.25
Volume
1,479,003
Avg. Vol
1,896,476
52-wk High
$77.79
52-wk Low
$60.01

MO.N

Chart for MO.N

About

Altria Group, Inc. is a holding company. The Company's segments include smokeable products, smokeless products and wine. The Company's subsidiaries include Philip Morris USA Inc. (PM USA), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (Middleton), which is engaged in the... (more)

Buy/Sell

Sell Hold Buy
1.87 Mean rating from 15 analysts

Overall

Beta: 0.63
Market Cap(Mil.): $120,006.40
Shares Outstanding(Mil.): 1,918.57
Dividend: 0.66
Yield (%): 4.22

BRIEF-Altria Reports Q4 Adjusted Earnings Per Share $0.91

* ALTRIA REPORTS 2017 FOURTH-QUARTER AND FULL-YEAR RESULTS; PROVIDES 2018 FULL-YEAR EARNINGS GUIDANCE

UPDATE 1-Two U.S. lawmakers voice concerns over Philip Morris tobacco trials

WASHINGTON, Jan 31 Two Democratic U.S. senators said they have fresh concerns over clinical trials conducted by Philip Morris International Inc as it seeks U.S. clearance to market its iQOS electronic tobacco product as less risky than cigarettes, according to statements both senators provided to Reuters.

Two U.S. lawmakers voice concerns over Philip Morris tobacco trials

WASHINGTON, Jan 31 Two Democratic U.S. senators said they have fresh concerns over clinical trials conducted by Philip Morris International Inc as it seeks U.S. clearance to market its iQOS electronic tobacco product as less risky than cigarettes, according to statements both senators provided to Reuters.

Vape shops sue to block U.S. regulation covering e-cigarettes

Jan 30 A group of vape shops in five U.S. states on Tuesday announced a trio of lawsuits challenging a rule adopted by the Food and Drug Administration that allows the regulator to treat e-cigarettes and similar devices like cigarettes.

UPDATE 3-U.S. panel deals blow to Philip Morris tobacco device

WASHINGTON, Jan 25 Philip Morris International Inc should not be allowed to claim its iQOS electronic tobacco product is less risky than cigarettes, U.S. health advisers said on Thursday, dealing a blow to the company as it seeks to strengthen its portfolio of alternative nicotine devices.

U.S. panel rejects Philip Morris claim iQOS reduces disease risk

Jan 25 Philip Morris International Inc should not be allowed to claim that its iQOS electronic tobacco device can reduce the risks of tobacco-related diseases for smokers who completely switch from cigarettes, a U.S. Food and Drug Administration advisory panel concluded on Thursday.

UPDATE 2-Philip Morris sees 6 mln U.S. smokers switching to iQOS device if cleared

WASHINGTON, Jan 24 Philip Morris International Inc told a U.S. advisory panel on Wednesday that it expects around 6 million smokers to switch completely to its iQOS electronic tobacco device if the company is allowed to claim it is less risky than cigarettes.

U.S. health advisers weigh risks of novel Philip Morris tobacco device

WASHINGTON, Jan 24 U.S. health advisers on Wednesday began to consider whether Philip Morris International Inc should be allowed to claim its novel electronic tobacco product is less harmful than cigarettes, potentially making it the first such device to carry a reduced risk claim.

Photo

U.S. FDA's tobacco stance faces test with Philip Morris iQOS device

WASHINGTON In a decision expected to test the Trump administration's approach to tobacco regulation, U.S. health advisers will vote this week on whether to allow Philip Morris International Inc to claim its novel iQOS tobacco device is less harmful than cigarettes.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.13%
Rohstoffe +0.10%
Industrie +0.04%
Konjunktur abhängige Waren & Dienstleistungen -0.04%
Konjunktur unabhängige Waren & Dienstleistungen +0.03%
Finanzindustrie -0.08%
Pharma -0.01%
Technologie +0.50%
Telekommunikation +0.29%